{"article_title": "Humana, Hurt By Sovaldi, Sees ACA And Medicare Boon In 2015", "article_keywords": ["aca", "sees", "hurt", "sovaldi", "medicare", "boon", "2015", "humana"], "article_url": "http://www.forbes.com/sites/brucejapsen/2014/11/07/humana-dogged-by-sovaldi-costs-now-sees-aca-and-medicare-boon-in-2015/", "article_text": "", "article_metadata": {"description": "Humana (HUM) said the high costs of the new hepatitis C pill Sovaldi and investments in government run exchanges where it offers plans under the Affordable Care Act were a drag on third-quarter earnings. Though Humana, like other insurers, is seeing big growth in individual customers who bought Obamacare coverage on [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Humana (HUM) said the high costs of the new hepatitis C pill Sovaldi and investments in government run exchanges where it offers plans under the Affordable Care Act were a drag on third-quarter earnings. Though Humana, like other insurers, is seeing big growth in individual customers who bought Obamacare coverage on [...]", "title": "Humana, Hurt By Sovaldi, Sees ACA And Medicare Boon In 2015", "url": "http://www.forbes.com/sites/brucejapsen/2014/11/07/humana-dogged-by-sovaldi-costs-now-sees-aca-and-medicare-boon-in-2015/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/11/sovaldi-1940x1298111111111111.jpg", "updated_time": "2014-11-07T10:50:09-05:00", "type": "article"}, "twitter": {"description": "Humana (HUM) said the high costs of the new hepatitis C pill Sovaldi and investments in government run exchanges where it offers plans under the Affordable Care Act were a drag on third-quarter earnings. Though Humana, like other insurers, is seeing big growth in individual customers who bought Obamacare coverage on [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/11/sovaldi-1940x1298111111111111.jpg", "title": "Humana, Hurt By Sovaldi, Sees ACA And Medicare Boon In 2015", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-11-07", "published": "2014-11-07", "id": "blogAndPostId/blog/post/2125-8712"}, "news_keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}